CNTB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Connect Biopharma Holdings Ltd (CNTB) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators show a lack of clear upward momentum, options data reflects low trading sentiment, and financial performance is weak with significant revenue decline. Without positive catalysts or strong trading signals, holding off on this stock is recommended.
The MACD histogram is negative (-0.0207) and expanding downward, indicating bearish momentum. RSI is neutral at 42.871, and moving averages are converging, showing no clear trend. The stock is trading below the pivot level (2.748), with key support at 2.462 and resistance at 3.035.
NULL identified. No recent news, significant trading trends, or influential figure activity.
Technical indicators show bearish momentum, and options data reflects low trading sentiment.
In Q3 2025, revenue dropped significantly by -98.69% YoY to $16,000. Net income improved slightly but remains negative at -$17,200,000 (up 33.58% YoY). EPS increased to -0.31 (up 34.78% YoY), and gross margin remained stable at 100%. Overall, financials are weak.
No data available for analyst ratings or price target changes.
